ECB: Domestic inflation has dropped slightly, but it is still at a high level. ECB: Staff now expect the economic recovery to be slower than predicted in September. As time goes on, the influence of restrictive monetary policy gradually fades, which should support the recovery of domestic demand. Domestic inflation has declined slightly, but it is still at a high level, mainly because wages and prices in some industries are still being adjusted to adapt to the past inflation surge.Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.
New Cape: At present, the company's revenue from AI products is not high. The new Cape said on the interactive platform on December 12 that the company actively explored in the field of artificial intelligence and gradually established its own AI corpus to support the research and development of intelligent services and products. At present, the company's AI product revenue is not high, which will not have a significant impact on the company's performance.Indian government sources: negotiations on a free trade agreement between India and Britain will begin at the end of January next year.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)
Dongyang Guangyao submitted a prospectus to be listed in Hong Kong by way of introduction. On December 11th, Dongyangguang Pharmaceutical, the controlling shareholder of Dongyangguang Changjiang Pharmaceutical, submitted a prospectus to the Hong Kong Stock Exchange to be listed in Hong Kong by way of introduction, and the exclusive sponsor was CICC.ECB: There is no pre-commitment to a specific interest rate path. The investment portfolio of the asset purchase plan declines at a controllable and predictable rate.Vassilis, a foreign exchange strategist, quickly commented on the ECB's resolution: the euro fell to a new low because the ECB gave up the "restrictive policy" part of the statement, but this does not mean that the policy language is downright dovish. Bonds in the euro zone are in a moderate trend.
Strategy guide
Strategy guide 12-13
Strategy guide
12-13